Fermenta Biotech Ltd

Promoter sale summary

• Target Company: Fermenta Biotech Limited.
• Disclosing party: Preeti Thakkar, promoter of Fermenta Biotech Limited (Promoter group).
• Transaction type: Sale of 11,65,938 equity shares (3.96%) in open market.
• Pre-transaction holding: 22,40,376 shares (7.61% voting rights).
• Encumbrances pre-transaction: None.
• Post-transaction holding: 10,74,438 shares (3.65%).
• Mode: Open market.
• Date of transaction: September 28, 2026.
• Equity share capital before/after: Rs. 14,71,54,935 in 2,94,30,987 shares.
• Total diluted capital after: Rs. 14,71,54,935 (2,94,30,987 shares).

Meeting Details

• Date: October 05, 2026; One-to-one; Physical; Mumbai.

Participants

• Key company participant: Company Secretary & Head – Legal.

Purpose

• Discuss press releases and investor presentations with investor(s).

Additional Notes

• Press releases and investor presentations available on company and stock exchange websites.

Fermenta Biotech Ltd - Trading Window closed from Oct 01, 2026 till 48 hours after the announcement of unaudited financial results for the quarter and half year ending Sep 30, 2026

Meeting Details

• Date: September 29, 2026
• Type/Mode: One-to-one; Physical meeting in Mumbai

Participants

• Company officials (management) to participate

Purpose

• Investor meeting to discuss investor interactions; press releases and investor presentations

Additional Notes

• Press releases and investor presentations will be available on the company's website

Meeting Details

• Date: September 24, 2026; time not disclosed.
• Type: one-to-one, mode: physical.
• Location: Mumbai.
• Organizer: Fermenta Biotech Ltd.
• Purpose: Investor interaction; discussion of press releases and investor presentations.
• Materials: Press releases and investor presentations available on company and stock exchange websites.

Meeting Details

• Date: September 22, 2026; Type: one-to-one meetings; Mode: physical; Location: Mumbai.

Participants

• Key company participant: Company Secretary & Head – Legal.

Purpose

• Intimation of investor meeting; discuss press releases and investor presentations.

Additional Notes

• Press releases and investor presentations available on company and stock exchange websites.

IEPF transfer details

• Subject: Transfer of unclaimed dividends for seven years to IEPF.
• Deadline to claim: 18 November 2026.
• Letters dispatched to shareholders on 16 September 2026.
• Shares and unclaimed dividend will be transferred to IEPF on a prescribed date.
• Earlier unclaimed amounts have already been transferred to IEPF.
• RTA for inquiries: MUFG Intime India Pvt. Ltd.; contact details in notice.
• Claims require folio/DP-CLID, holder name, contact, email, and KYC documents.

License details

• Exclusive licence with VIT for commercialising natural in-situ Vitamin B12 fortification in fermented foods.
• Technology enables B12 enrichment during fermentation with minimal production changes.
• Indian Patent Application No. 202441015300; CBST at VIT developed the process.
• Lab studies show ~80% retention of B12 after cooking.
• Next phase includes application development, nutritional validation, regulatory evaluation, and commercial solutions.

Parties and status

• Parties: Fermenta Biotech Limited and VIT Vellore.
• No disclosed financial terms in the filing.
• Press release issued; no regulatory approvals indicated.
• Commercial potential spans FMCG, food & nutrition, nutraceuticals.

Meeting Details

• Date: September 03, 2026 (time not disclosed)
• Type: One-to-one meetings
• Mode: Physical
• Location: Mumbai
• Organiser: Fermenta Biotech Limited
• Purpose: Investor interaction; discuss press releases and investor presentations
• Participants: Company officials; Company Secretary & Head – Legal
• Availability: Press releases and investor presentations available on company and stock-exchange websites